Prophylactic antimicrobial drugs to pregnant women colonized with group B streptococcus
- Authors: Oganyan K.A.1, Arzhanova O.N.1, Savicheva A.M.1, Zatsiorskaya S.L.1
-
Affiliations:
- D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS
- Issue: Vol 64, No 2 (2015)
- Pages: 59-63
- Section: Articles
- URL: https://journal-vniispk.ru/jowd/article/view/1263
- DOI: https://doi.org/10.17816/JOWD64259-63
- ID: 1263
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Kristina Al’bertovna Oganyan
D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS
Email: 2743856@mail.ru
doctor, Dep. of Pathology of pregnancy
Ol’ga Nikolaevna Arzhanova
D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS
Email: arjanova_olga@mail.ru
MD, Professor. Head of the Department of Pathology of pregnancy
Alevtina Mikhaylovna Savicheva
D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS
Email: savitcheva@mail.ru
head of Laboratory of Microbiology
Svetlana L’vovna Zatsiorskaya
D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS
Email: iagmail@ott.ru
doctor, Lab. of Microbiology
References
- Анкирская А. С. Роль стрептококков группы В в перинатальной патологии. Акушерство и гинекология. 1984; 9: 6-10.
- Зациорская С. Л. В-стрептококковая инфекция у новорожденных детей в зависимости от массивности колонизации. Актуальные вопросы физиологии и патологии репродуктивной функции женщин: Материалы XXII научной сессии НИИ акушерства и гинекологии. Айламазяна Э. К., ред. СПб.; 1993; 61-3.
- Оганян К. А. Течение и исход беременности при колонзации мочеполового тракта женщин стрептококками группы В и D. Дис. канд. мед. наук. СПб.; 2008.
- Тотолян А. А. Стрептококки группы В в патологии человека. Тотолян А. А., ред. СПб.: Человек; 2009.
- Baker C. J. Group B streptococcal infections. In infectious diseases of the fetus and newborn infant. The W. B. Saunders Co. 3rd ed. Philadelphia; 2004: 980-1054.
- Crespo-Ortiz Mdel P. Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study. BMC Infect Dis; 2014: 428.
- Domelier A. S. Loss of Catabolic Function in Streptococcus agalactiae Strains and Its Association with Neonatal Meningitis. J. Clin. Microbiol. 2006; 44: 3245-50.
- Edwards M. S. Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 2005; 41: 839-47.
- Faxelius G. Neonatal septicemia due to group B streptococci - perinatal risk factors and outcome of subsequent pregnancies. J. Perinat. Med. 1988; 16: 423-30.
- Gilson G. J. Prevention of group B streptococcus early-onset neonatal sepsis: comparison of the Centers for Disease Control and Prevention screening-based protocol to a risk-based protocol in infants at greater than 37 weeks' gestation. J. Perinatol. 2000; 20: 491-5.
- Matorras R. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 1991; 40: 57-2.
- Mahieu L. Management of the neonate at risk for early-onset Group B streptococcal disease (GBS EOD): new paediatric guidelines in Belgium. Acta Clin Belg: 2014; 69 (5): 313-9.
- Ohlsson A. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev: 2014; CD007467.
- Provisional Recommendations for the Prevention of Perinatal Group B Streptococcal Disease Date of posting of provisional recommend. Guidelines in CDC Morb. and Mortal. Wkly Rep. 2010.
- Six A. Maternal and perinatal infections to Streptococcus agalactiae. Presse Med: 2014; 43 (6 Pt 1): 706-14.
Supplementary files
